Dr. Raut's Women's Hospital

19/08/2026

𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝗳𝗲𝗿𝘁𝗶𝗹𝗶𝘁𝘆 𝗥𝗮𝘁𝗲𝘀 𝗔𝗿𝗲 𝗥𝗶𝘀𝗶𝗻𝗴. 𝗧𝗵𝗲 𝗜𝗺𝗺𝘂𝗻𝗲 𝗔𝗻𝘀𝘄𝗲𝗿 𝗡𝗼𝗯𝗼𝗱𝘆 𝗜𝘀 𝗗𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗻𝗴:

Infertility is no longer a niche clinical problem. It is a growing global health concern - yet one important biological dimension remains largely outside the mainstream conversation: the immune system.

The usual explanations are well recognised: delayed parenthood, lifestyle and metabolic factors, environmental exposures, and declining reproductive health.

But IVF specialists also see another group repeatedly: patients with good embryos, an optimised endometrium and largely normal standard investigations - yet continued implantation failure, biochemical pregnancies or early losses.

Pregnancy requires more than embryo and endometrium. It requires a carefully regulated maternal–fetal immune dialogue involving allo-recognition, immune tolerance, cytokine balance and NK-cell regulation.

At Dr. Raut's Centre for Reproductive Immunology (ICPRM), our position is not that reproductive immunology belongs in every fertility workup. It is that in selected patients with recurrent implantation failure, recurrent pregnancy loss or otherwise unexplained reproductive failure, the immune dimension deserves consideration before another cycle repeats the same unanswered question.

𝑫𝒓. 𝑴𝒐𝒉𝒂𝒏 𝑹𝒂𝒖𝒕 𝒂𝒏𝒅 𝑫𝒓. 𝑴𝒖𝒈𝒅𝒉𝒂 𝑹𝒂𝒖𝒕 𝒉𝒂𝒗𝒆 𝒘𝒐𝒓𝒌𝒆𝒅 𝒂𝒕 𝒕𝒉𝒊𝒔 𝒊𝒏𝒕𝒆𝒓𝒔𝒆𝒄𝒕𝒊𝒐𝒏 𝒇𝒐𝒓 𝒐𝒗𝒆𝒓 𝟑𝟎 𝒚𝒆𝒂𝒓𝒔 - 𝒍𝒐𝒏𝒈 𝒃𝒆𝒇𝒐𝒓𝒆 𝒓𝒆𝒑𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒗𝒆 𝒊𝒎𝒎𝒖𝒏𝒐𝒍𝒐𝒈𝒚 𝒆𝒏𝒕𝒆𝒓𝒆𝒅 𝒕𝒉𝒆 𝒘𝒊𝒅𝒆𝒓 𝒇𝒆𝒓𝒕𝒊𝒍𝒊𝒕𝒚 𝒄𝒐𝒏𝒗𝒆𝒓𝒔𝒂𝒕𝒊𝒐𝒏.

As infertility rates rise, the case for a more integrated referral pathway becomes stronger.

And importantly, ICPRM works with IVF specialists, not around them. The IVF plan remains central; our role is to evaluate the immune dimension in selected patients and complement the treating specialist’s approach.

The infertility challenge is growing. Addressing it will require the field to look beyond the conventional variables.

®

15/08/2026

13/08/2026

🌸 From Heartbreak to Holding Their Little Miracle 🌸

For Reema (37) and Rahul (39) (names changed), seven years of marriage carried one cherished dream - to become parents.

Their journey was difficult: unexplained infertility followed by two heartbreaking miscarriages at 19 weeks and 8 weeks, despite routine BOH investigations being normal.

When specialised immunological investigations indicated an allo-immune problem, the couple underwent ImmuLIT® treatment at Dr. Raut’s Centre for Reproductive Immunology.

Within 2 months, she conceived.

This time, the pregnancy progressed uneventfully, and the couple finally welcomed a healthy baby girl.

After the delivery, an overwhelmed Rahul wrote:

“You haven't just given us a child — you've given us our world.” ❤️

From repeated loss and unanswered questions to finally holding their daughter - their journey is a beautiful story of hope, perseverance and parenthood.

Sometimes, when routine reports are normal, looking deeper may provide new insights.

Individual outcomes vary. Evaluation and treatment should be individualized under appropriate medical guidance.

®

12/08/2026

Is ImmuLIT® safe? It’s one of the most important questions patients ask us - and one that deserves an evidence-based answer.

With over 30 years of clinical use, ImmuLIT® is a patented immunotherapy approach used in reproductive immunology.

Watch the video as we address the safety of the procedure, what the evidence tells us, and why patients can approach it with confidence.

Have questions about ImmuLIT®? We’re here to help.

Dr. Raut’s Centre for Reproductive Immunology

📞 Contact: +919820894047 +919820183757

®

11/08/2026

𝗧𝗛𝗘 𝗥𝗘𝗔𝗦𝗢𝗡 𝗕𝗘𝗛𝗜𝗡𝗗 𝗢𝗨𝗥 𝗦𝗠𝗜𝗟𝗘𝗦...
“After 12 years of waiting and heartbreak, holding our little girl in our arms feels like a dream finally come true.”

Their journey to parenthood had been anything but easy.

12 years of infertility.
13 failed IUIs.
4 failed IVFs.
4 heartbreaking miscarriages.

Despite trying again and again, the reason remained unexplained.

Until immunological investigations revealed a possible missing piece ... an allo-immune problem.

She underwent ImmuLIT® treatment at Dr. Raut’s Centre for Reproductive Immunology and went on to conceive in her very next IVF cycle.

This time, their hope stayed.

The pregnancy was uneventful, and after years of waiting, they finally welcomed their healthy baby girl.

Their little girl became the reason behind their smile…
and their smile became 𝗧𝗛𝗘 𝗥𝗘𝗔𝗦𝗢𝗡 𝗕𝗘𝗛𝗜𝗡𝗗 𝗢𝗨𝗥 𝗦𝗠𝗜𝗟𝗘𝗦...!

𝐼𝑚𝑚𝑢𝐿𝐼𝑇® 𝑖𝑠 𝑐𝑜𝑛𝑠𝑖𝑑𝑒𝑟𝑒𝑑 𝑓𝑜𝑟 𝑎𝑝𝑝𝑟𝑜𝑝𝑟𝑖𝑎𝑡𝑒𝑙𝑦 𝑠𝑒𝑙𝑒𝑐𝑡𝑒𝑑 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑓𝑜𝑙𝑙𝑜𝑤𝑖𝑛𝑔 𝑟𝑒𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑣𝑒 𝑖𝑚𝑚𝑢𝑛𝑜𝑙𝑜𝑔𝑦 𝑒𝑣𝑎𝑙𝑢𝑎𝑡𝑖𝑜𝑛; 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝑜𝑢𝑡𝑐𝑜𝑚𝑒𝑠 𝑚𝑎𝑦 𝑣𝑎𝑟𝑦.

11/08/2026

Not every unexplained fertility problem needs another treatment.

Sometimes it needs another evaluation.

For Family Physicians, gynaecologists, IVF specialists and for that matter any doctor of any speciality, three situations may warrant considering a reproductive immunology opinion:

→ Unexplained infertility despite a normal routine work-up

→ Two or more miscarriages, late miscarriage, or early-onset pregnancy-induced hypertension where common causes remain unexplained

→ Failed IVF cycle(s) despite good-quality embryos, with no clear explanation for failure

A referral to Dr. Raut’s Centre for Reproductive Immunology (ICPRM) is not a referral away from the GP or IVF specialist.

We are not an alternative to IVF.

Our role is to evaluate the reproductive immune component, intervene where clinically indicated, and collaborate with the patient's existing doctors.

We evaluate. We treat where indicated. We collaborate. Your patient returns to you.

For referrals or a doctor-to-doctor discussion:
+919820894047, +919720183756
[email protected] | [email protected] | icprm.in

®

09/08/2026

𝐖𝐡𝐞𝐧 𝐚 𝐫𝐞𝐟𝐞𝐫𝐫𝐢𝐧𝐠 𝐜𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧 𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐬 𝐲𝐨𝐮𝐫 𝐰𝐨𝐫𝐤, 𝐢𝐭 𝐦𝐞𝐚𝐧𝐬 𝐬𝐨𝐦𝐞𝐭𝐡𝐢𝐧𝐠 𝐬𝐩𝐞𝐜𝐢𝐚𝐥. ❤️
Today at GCUOG 2026 International Conference, Hyderabad, Dr Aradhya Achuri presented our clinical work:

“𝗣𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆 𝗢𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗙𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝗠𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗜𝗺𝗺𝘂𝗻𝗲 𝗠𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗜𝗺𝗺𝘂𝗟𝗜𝗧® 𝗶𝗻 𝗪𝗼𝗺𝗲𝗻 𝘄𝗶𝘁𝗵 𝗥𝗲𝗰𝘂𝗿𝗿𝗲𝗻𝘁 𝗣𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆 𝗟𝗼𝘀𝘀 𝗮𝗻𝗱 𝗥𝗲𝗰𝘂𝗿𝗿𝗲𝗻𝘁 𝗜𝗺𝗽𝗹𝗮𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗙𝗮𝗶𝗹𝘂𝗿𝗲: 𝗔 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲.”

This presentation was particularly meaningful for us at Dr. Raut’s Centre for Reproductive Immunology.
Dr. Aradhya is an IVF specialist from Hyderabad (Apollo Fertility), who refers selected patients with recurrent implantation failure and recurrent pregnancy loss to us for reproductive immunology evaluation and treatment.

And today, she stood before her peers and presented the outcomes of those patients.

That, for us, represents an important evolution.

Reproductive immunology cannot exist in isolation.

The best care emerges when the IVF & reproductive medicine specialist and reproductive immunology team work together - each bringing their expertise to some of the most difficult patients we encounter in fertility practice.

Our real-world cohort included 49 women with recurrent reproductive failure who underwent treatment with our single-session lymphocyte immunotherapy protocol, ImmuLIT®, out of which 𝟖𝟎% achieved a viable pregnancy with fetal cardiac activity.

These findings are encouraging, but they must be interpreted appropriately.

Though this is a retrospective, uncontrolled real-world cohort, it is an important clinical signal, favouring ImmuLIT® procedure.

And then came a comment after the presentation that made the day even more memorable.

One of the judges told Dr. Aradhya:
“Next year, try for a poster at ESHRE.” ❤️
Sometimes a few words are enough.

Today seeing a clinician who refers patients to us independently take this clinical experience to an obstetrics and gynaecology conference, feels like another important step in bringing reproductive immunology into wider scientific discussion.

The journey we hope to build is simple:
Difficult clinical problem → thoughtful patient selection → collaboration → outcomes → data → scientific scrutiny → better evidence.

Congratulations, Dr Aradhya Achuri for taking this work to the podium and presenting it before your peers.

And thank you to every reproductive medicine specialist who entrusts us with patients after repeated implantation failures and pregnancy losses.

We still have much to learn.

But today gave us another reason to keep asking the questions.

GCUOG 2026.

Next stop? ESHRE!!!❤️

06/08/2026

𝐅𝐫𝐨𝐦 𝐓𝐡𝐫𝐞𝐞 𝐏𝐫𝐞𝐠𝐧𝐚𝐧𝐜𝐲 𝐋𝐨𝐬𝐬𝐞𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐉𝐨𝐲 𝐨𝐟 𝐓𝐰𝐢𝐧𝐬 ❤️👶👶

Every successful pregnancy reminds us why perseverance, science, and personalized care matter.

A young couple came to us after experiencing three consecutive unexplained pregnancy losses in 4 years of their marriage, carrying not only medical challenges but also immense emotional pain.

Recurrent pregnancy loss can be devastating, leaving families searching for answers and hope.

Following a comprehensive reproductive immunology evaluation, an individualized treatment plan was designed to address the underlying factors contributing to their pregnancy losses.

ImmuLIT® our patented and branded process of active immunomodulation was given . This was followed by Individualised passive immunomodulatory protocol during pregnancy.

Today, we are overjoyed to celebrate their success!

The couple has welcomed healthy twins, turning years of heartbreak into double the happiness.

This case highlights an important message: 𝗡𝗼𝘁 𝗮𝗹𝗹 𝗿𝗲𝗰𝘂𝗿𝗿𝗲𝗻𝘁 𝗽𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆 𝗹𝗼𝘀𝘀𝗲𝘀 𝗮𝗿𝗲 𝗱𝘂𝗲 𝘁𝗼 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗼𝗿 𝗵𝗼𝗿𝗺𝗼𝗻𝗮𝗹 𝗰𝗮𝘂𝘀𝗲𝘀..

Immunological factors can play a crucial role, and timely evaluation can make a meaningful difference in patient outcomes.

With the right immune evaluation, evidence-based treatment, and compassionate care, many couples can go on to achieve their dream of parenthood.

Every success story strengthens our commitment to advancing reproductive immunology and delivering personalized care to couples facing recurrent pregnancy loss.

𝑃𝑎𝑡𝑖𝑒𝑛𝑡 𝑖𝑑𝑒𝑛𝑡𝑖𝑡𝑦 ℎ𝑎𝑠 𝑏𝑒𝑒𝑛 𝑝𝑟𝑜𝑡𝑒𝑐𝑡𝑒𝑑, 𝑎𝑛𝑑 𝑡ℎ𝑖𝑠 𝑐𝑎𝑠𝑒 𝑖𝑠 𝑠ℎ𝑎𝑟𝑒𝑑 𝑤𝑖𝑡ℎ 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑖𝑛𝑡𝑒𝑛𝑡 𝑎𝑛𝑑 𝑐𝑜𝑛𝑠𝑒𝑛𝑡 𝑤ℎ𝑒𝑟𝑒 𝑎𝑝𝑝𝑙𝑖𝑐𝑎𝑏𝑙𝑒.


®

05/08/2026

What Is ImmuLIT®? Everything You Need to Know Before Your First Question

ImmuLIT® is a procedure that helps the maternal immune system do something it is struggling to do on its own: recognise and protect the pregnancy.

For many women facing recurrent pregnancy loss or unexplained IVF failures, the issue isn't always quality or health - it’s recognition.

Why Allo-Immune Failure Happens?
An embryo carries 50% of the father’s genetic material. Naturally, the maternal body should recognise this, adapt, and produce protective "blocking antibodies.

In allo-immune failure, those antibodies aren't produced. Instead of nurturing the embryo, the immune system views it as a foreign threat.

What Is ImmuLIT®?
ImmuLIT® uses isolated lymphocytes from the partner to "train" the mother’s immune system, helping her body accept and protect the embryo rather than attack it.

What Sets ImmuLIT® Apart?
1. 30+ Years of Clinical Evidence: Backed by decades of refined medical experience.
2. Patented & Government-Cleared: Performed in a fully certified, specialized centre.
3. Doctor-Led Ex*****on: Conducted personally by Dr. Mohan Raut and Dr. Mugdha Raut at every step.
4. Simple, Outpatient Procedure: Completed in a single 3-hour sitting—no hospital admission, no general anesthesia.
5. 100% Personalised: ImmuLIT® is never prescribed without a comprehensive immune evaluation. Your treatment protocol is built around your body's unique immune picture.

Where Do You Start?
If you’ve been wondering whether immune factors could be playing a role in your fertility journey, the full immune evaluation is where that question finally gets answered.

Every journey begins with clarity.

Learn more or book a personal consultation:
📞 Contact: +919820894047 +919820183757

®